These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36839432)

  • 1. Do We Have Enough Evidence to Specifically Recommend Transoral Robotic Surgery in HPV-Driven Oropharyngeal Cancer? A Systematic Review.
    De Virgilio A; Costantino A; Rizzo D; Crescio C; Gallus R; Spriano G; Mercante G; Festa BM; Accorona R; Pignataro L; Capaccio P; Bussu F
    Pathogens; 2023 Jan; 12(2):. PubMed ID: 36839432
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know.
    Molteni G; Bassani S; Arsie AE; Zampieri E; Mannelli G; Orlandi E; Bossi P; De Virgilio A
    Healthcare (Basel); 2024 May; 12(10):. PubMed ID: 38786424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of transoral robotic surgery in the management of oropharyngeal cancer.
    Dias FL; Walder F; Leonhardt FD
    Curr Opin Oncol; 2017 May; 29(3):166-171. PubMed ID: 28252460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
    Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral robotic surgery and intensity-modulated radiotherapy in the treatment of the oropharyngeal carcinoma: a systematic review and meta-analysis.
    De Virgilio A; Costantino A; Mercante G; Pellini R; Ferreli F; Malvezzi L; Colombo G; Cugini G; Petruzzi G; Spriano G
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1321-1335. PubMed ID: 32696250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
    Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
    Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 10. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
    Brody RM; Shimunov D; Cohen RB; Lin A; Lukens JN; Hartner L; Aggarwal C; Duvvuri U; Montone KT; Jalaly JB; LiVolsi VA; Carey RM; Shanti RM; Rajasekaran K; Chalian AA; Rassekh CH; Cannady SB; Newman JG; O'Malley BW; Weinstein GS; Gimotty PA; Basu D
    Oral Oncol; 2022 Apr; 127():105798. PubMed ID: 35245888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
    Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of T1-T2 stage oropharyngeal squamous cell carcinoma treated with transoral robotic surgery.
    Li H; Zhang X; Chen W; Zhang Q; Li Q; Chen S; Yang Z; Su X; Yan S; Yang A; Song M
    Laryngoscope Investig Otolaryngol; 2023 Feb; 8(1):103-112. PubMed ID: 36846425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience.
    Meccariello G; Montevecchi F; D'Agostino G; Iannella G; Calpona S; Parisi E; Costantini M; Cammaroto G; Gobbi R; Firinu E; Sgarzani R; Nestola D; Bellini C; De Vito A; Amadori E; Vicini C
    Acta Otorhinolaryngol Ital; 2019 Apr; 39(2):75-83. PubMed ID: 31097824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid Usage and Prescribing Predictors Following Transoral Robotic Surgery for Oropharyngeal Cancer.
    Abt NB; Holcomb AJ; Feng AL; Suresh K; Mokhtari TE; McHugh CI; Parikh AS; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Laryngoscope; 2021 Jun; 131(6):E1888-E1894. PubMed ID: 33210756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.